about
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...
Read More
2.79
0.03
(1.09%)
2.7M
XNAS Volume
XNAS 07 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..